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UM4D4 (CDw60), the surface molecule of a novel antigen-
independent T-cell activation pathway, was found to be 
highly expressed on lesional psoriatic T cell s. To examine 
whether UM4D4 represents aT-cell activation pathway for 
psoriatic T cells, aT-cell line was initiated from an acute 
skin lesion and cloned by limiting dilution. Clonality was 
verified by analysis of T-cell receptor gene rearrangement. 
All T -cell clones tested, whether CD4+2H4+CD8-, 
CD4+2H4-CD8-, or CD4-CD8+CDllb-, expressed 
UM4D4 and were activated by the monoclonal antibody 
anti-UM4D4. Lesional psoriatic T-cell clones were hetero-
geneous in the degree of anti-UM4D4-induced prolifera-
Psoriasis is an inflammatory skin disease that involves an increase in the proliferative keratinocyte population [1 J. Epidermal and dermal inflammatory cells are present early in the evolution of a lesion [2-4] and are mainly composed of macrophages and activated T cells [4-7]. 
Lymphokine release from activated T cells may directly modulate 
kerarinocyte differentiation, function, and growth regulation [8-
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tion and in their production of IL-2 and gamma-interferon. 
Lymphokines released by anti-UM4D4 activation were capa-
ble of inducing ICAM-l and HLA-DR expression on cul-
tured normal keratinocytes. Thus, th e high' expression of 
UM4D4 on T-cells in psoriatic skin provides an alternative 
mechanism for T-cell activation that may be operative in the 
psoriatic lesional milieu. Indeed, activation oflesional T -cells 
through the UM4D4 molecule resulted in release of lym-
phokines that directly induced keratinocytes to express a phe-
notype displayed in psoriatic skin lesions. ] ImJest Dermatol 
95:275 -282, 1990 
10] . Psoriatic epidermis exhibits evidence of exposure to T-cell 
lymphokines in the local milieu in that keratinocytes abnormall y 
express HLA-DR intercellular adhesion molecule-1 (ICAM-1) 
[4 ,11 - 14], and IP-10 [15], which are al l gamma-interferon (IFN)-
inducible molecu les on keratinocytes in vitro [1 6-21]. Alterna-
tively, T-cell Iymphokines may have indirect effects on keratino-
cyte growth mediated through induction of cytokine release by cells 
of monocyte/macrophage, endothelial, or fibroblastic derivation. 
Elucidation of mechanisms by which psoriatic T cells achieve and 
maintain their activated state in lesions is critical for better under-
standing of the pathogenesis of psoriasis. Human T-lymphocyte 
activation can be initiated through both antigen-dependent and 
-independent pathways. Antigen-dependent activation Occurs 
through interaction of the T-cell receptor complex with antigen-
presenting cells and the nominal antigen [22] . We have recently 
demonstrated the increased capacity of antigen-presenting psoriatic 
epidermal cells to activate alloantigen-reactive peripheral blood T-
cells [4] . The CD2 (Tll, sheep erythrocyte receptor) protein repre-
sents the surface structure of a well-defined antigen-independent 
T-cell activation pathway [23]. Recently, another novel pathway of 
human T-Iymphocyte activation, identified by the monoclonal an-
tibody anti-UM4D4, has been described [24J . 
Anti-UM4D4 identifies a surface structure termed UM4D4 
(CDw60), and was generated against a synovial T-cell line from a 
patient with classical rheumatoid arthritis. The antibody reacts 
strongly with JT)ost rheumatoid synovia l T cells and a small subset of 
peripheral blood T cells, resting or activated [24]. Anti-UM4D4 is 
mitogenic in soluble form for certa in T-cell clones even in the 
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absence of accessory cells. Moreover, the surface structure of 
U M4D4 is distinct from other T-cell surface activating molecules 
such as CD2, CD3, CD 28, and the T-cell receptor [24]. The mito-
genic effect of anti-UM4D4 suggests that UM4D4 could playa role 
in the in vivo activation of a subset of T cells. 
Psoriasis and rheumatoid arthritis have some common features. 
Both are characterized by compartmentalization of activated T cells 
in association with hyperproli feration of local tissue (hyperprolifer-
ation of the epidermis in psorias is and hyperprolife ration of the 
synovium in rheumatoid arthritis)[1,3,25- 29J. Furthermore, psor-
iatic patients frequently have an associated inflammatory arthritis. 
Due to these similarities, we have characterized the expression of 
UM4D4 on T cell s in psoriatic lesions with respect to other known 
T -cell markers, and compared the percentage ofUM4D4+ T cells in 
skin lesions and peripheral blood of psoriatic patients. To examine 
whether UM4D4 can participate in the activation of lesional T 
cells, clones were isolated by limiting dilution from T -cell line 
ini tiated from an acute psoriatic lesion and characterized by T -cell 
receptor gene rearrangement analysis and immunophenotyping. 
T hese clones were then characterized with respect to proliferation 
and cytokine release in response to anti-UM4D4 stimulation, dem-
onstrating proliferative competence and functional heterogeneity 
in terms of differential release of interleukin-2 and interferon-
gamma (IFN -Y)· Finally, the ability of these T cells to stimulate 
keratinocytes was assessed by analys is of induction of ICAM-l and 
HLA-DR cell-surface expression in response to conditioned me-
dium fro m UM4D4-stimulated clones . These results document a 
pathway by which T cells actually contained in psoriatic lesions can 
directly induce keratinocytes to assume a phenotype displayed in 
psoriatic lesions. . 
MATERIALS AND METHODS 
Initiation ofLesional P soriatic T-Cell Lines and Clones In 5 
patieilts, punch biopsies were obtained from acutely expanding 
psoriatic plaque lesions that had been treated with emollients alone 
for at least 1 week. The biopsies were cut horizontally, as close to 
the epidermis as possible, and then vertically into several 1 mm2 
pieces. These specimens were incubated in RPMI 1640 containing 
10% human AB serum, 50 u11lts/ml of recombinant IL-2 (rIL-2) 
(Cellular Products, Buffalo, NY), glutamine, and antibiotics in a 
24-microwell plate at 37° C. Following 12 h of incubation, T cells 
were seen migrating out from the biopsy fragments. However, only 
in 1 of 5 patients was it possible to establish an expanding T-cell 
line. T his T -cell line was cloned using limiting dilution . Briefl y, the 
T cells were plated at 0.3 cell s per well in 96-well V -bottom micro-
titer plates (Flow Laboratories, MacLean, VA), along with 50,000 
autologous y-irradiated (5000 RAD) mononuclear cells, 50 U Iml of 
rIL-2, and one ,ug/ml of phytohemaglutinin (PHA) (Burroughs 
W ellcome, Greenville, NC) . When growth was observed, the cells 
were subsequently transferred to flat bottom plates and restimulated 
with anti-CD3 (Coulter Clone, Hialeah, FL), or PHA and autolo-
gous mononuclear cells every 1 - 4 weeks. The clones were ex-
panded and were maintained for up to 1 year, until senescence and 
death supervened. 
Monoclonal Antibodies for Phenotypic Characterization 
Anti-Leu5b (anti-CD 2) (Becton Dickinson, Mountainview, CA) 
binds to all E+ T cel ls. OKT3 (Ortho Diagnostic, Raritan, NJ) 
identifies an epitope on the CD3 molecule that is expressed by all 
mature T cells. Leu2a (Becton Dickinson) detects the CD8 determi-
nant on suppressor/cytotoxic T cell s, whereas the C D4 determi-
nant expressed on helper-inducer T cells is detected by Leu3a (Bec-
ton Dickinson). Anti-2H4 defines a determinant on the CD45 
complex (CD4SR) expressed on the human CD4+ subset that in-
duces T-suppressor lymph0S:'yte function and was a generous gift of 
Dr. C. Morimoto and Dr. S. Schlossman. Anti-Leu 15 detects an 
epitope on the CD11b molecule that is expressed on the CD8+ 
lymphocyte subset that fun ctions as suppressor/effector cells. Anti-
H LA-DR (Becton Dickinson) is directed against a public epitope on 
the HLA-DR molecule. Anti-RR1 / l detects ICAM-l and was 
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kindly provided by Dr, Brian]. Nickoloff (University of Michigan 
Ann Arbor, MI) . Anti-UM4D4 is an IgM monoclonal antibody that 
identifies CDw60, a surface molecule expressed on a subset of pe, 
ripheral blood T cells [24J . 
Two-Color Staining of Histologic Sections Punch biopsie~ 
from 7 untreated patients with acutely expanding plaque-stage pso, 
riasis were embedded and frozen in Tissue T ek II O .C.T. corn, 
pound (Miles Laboratories Inc. , N apierville, IL) and stored at 
- 70"C. Six-micron sections were cut on a cryostat and air-dried, 
The sections were first incubated with anti-UM4D4 (murine IgM) 
and with anti-Leu 5b (murine IgG), and in some experiments wit~ 
anti-Leu 3a (murine IgG) or anti-Leu 2a (murine IgG) or isotyp() 
controls (Becton Dickinson) . Second-step staining was performe~ 
using rhodamine-conjugated goat anti-mouse IgM, mft-chain spe, 
cific (Tago Inc. Burlingham, CAl, and fluorescein-conjugated goat 
anti-mouse IgG (Kirkegaard, Gaithensburg, MD). Specimens wer~ 
incubated with the primary antibodies for 45 min foll owed by thr~ 
5-min washes, and then incubated with the second-step antibody 
for 30 min. A Nikon fluorescence microscope with appropria~ 
filters was used for scoring. The entire dermis of sections from each 
of 7 patients was scored as the % of C D2+ T-cells (green fluore.-
sence), which also expressed UM4D4 (red flu orescence). 
Flow-Cytometric Analysis of Peripheral Blood Mononu, 
clear Cells Analysis of cell-surface antigens was performed on a, 
Coulter model EPICS C fl ow cytometer with an excitation wave-
length of 488 nm. Mononuclear cells (MNC) obtained from hepa, 
rinized venous blood following Ficoll Hypaque density-gradient 
centrifugation were double stained with anti-UM4D4 and ph " 
coerythrin-conjugated T3 (anti-CD3, Coulter Clone, Hialeah, FL), 
Anti-UM4D4 was identified with fluorescein-conjugated goat 
anti-mouse IgM mfL chain specific. Analysis was performed on 5000 
cells and the acquired data was ·expressed as percent of CD3+ T cells 
that co-express UM4D4. 
Mitogenic Effect of Anti-UM4D4 Assays were performed Ut 
triplicate wells in 96-well U-bottom plates (Costar, Cambridg~, 
MA). T o 40,000 T cells in a final volume of 0.2 ml RPMI 1640 with 
10% AB serum was added tetradecanoyl phorbol acetate (PMA) at l 
ng/ml, or anti-UM4D4 ascites fluid (1 / 100). The cultures were-
pulsed at 24 h with 1 fLCi/ well 3[HJTdR, harvested 18 h later, an~ 
counted in a liquid scintillation counter. The mean CPM ± S.m.1 
was determined for each triplicate set of wells. 
Interferon Gamma Production The cell-free supernatants 
from both unstimulated and stimulated T cells were analyzed fat 
interferon- gamma production using a commercially available ra, 
dioi·mmunoassay kit (Centocor, Malvern, PAl. 
Interleukin-2 Release Supernatants were tested for IL-2 activit) 
by using a microassay based on the viability of an IL-2-dependCl\t 
murine T -cell line, HT2. Six thousand HT2 cells were cultured itt 
120-fLJ volumes in fl at-bottomed microplate wells in the presence ot 
doubling dilutions of supernatants or a rat T-cell growth factor 
(TCGF) standard (100 /l/ml) . After 44 h of incubation, 10 
of 3-(4,5-dimethylthiazol-2-yl)-2,Sdiphenyl- tetrazolium bromid~ 
(MTT, 5 mg/ml) was added to each well and incubated for 4 h at 
3TC. Viable cells reduce the MTT to a purple precipitate. Aftet 
addition of acidic isopropanol, the absorbance of each well .. ,-
determined at two wavelengths, 570 nm and 620 nm, and the del 
absorbance was calculated with a titertek ELISA reader. The amount 
ofIL-2 activity per supernatant was calculated basically according 
the method of Gillis et al [30J . 
Keratinocyte Cultures Human epidermis was obtained by ken, 
tome biopsy using 1 % lidocaine anesthesia. The blade depth was 
at 0.2 mm and tissue was obtained from the hips or buttocks 
healthy volunteers. Keratinocytes were disaggregated from the tis, 
sue with ttypsin/ EDTA (0.25%/0.1 %) for 30 min at 37°C. Th~ 
tissue was placed stratum corneum side down in a plastic petri dish 
and scraped with a scalpel in McCoy'S media containing 10% fe 
calf serum. Cell aggregates were disassociated by pipeting and th~ 
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cell suspension passed through a nylon membrane to remove large 
debris. Cells were pelleted by centrifugation and resuspended in low 
calcium serum free media (Modified MCDB 153) (Clonetics Inc., 
San Diego, CAl, supplemented with insulin (5 ,ug/ml) , hydrocorti-
sone (0.5 ,ug/ml), epidermal cell growth factor (10 ng/ml), and 
bovine pituitary extract (70,ug of protein/ml), and plated in 75 cm2 
culture flasks at 2 X 107 cells/flask. Upon confluence, cells were 
detached in 0.025% trypsin/O.Ol % EDTA, and passed into 35-mm 
dishes (105 cells/dish). Cells were utilized between passages 2-5. 
T-Cell Receptor Gene Rearrangement DNA was isolated 
from 5 - 8 X 106 cells of each clone by SDS-proteinase K digestion 
'and phenol-chloroform extraction [31]. DNA was quantitated by 
absorbance at 260 nm and 5-10,ug DNA was digested at 3TC, 
with 15 units of Eco RI or Hind III restriction endonucleases in the 
buffers supplied by the manufacturer (BRL, Bethesda, MD). After 
overnight di gestion, 10 units of enzyme was added and digestion 
continued an additional 6 h. The di gested DNA samples were sub-
jected to electrophoresis in 0.8% agarose gels in 40 mM Tris-ace-
tate, 1 rnM EDTA (pH 8.0), depurinated in 0.25 M HCI for exactl y 
10 min, rinsed, and immediately blotted onto derivatized nylon 
membranes (Zeta-Probe, Bio-Rad) in 0.4 M N aOH, as described by 
the manufacturer. Blots were hybridized, washed, and autoradio-
graphed as described [32] using as probe the CfJ2 cDNA insert 
JUR-P2, which hybridizes to the CfJ1 and CfJ2 regions of the T-cell 
receptor gene [33J. Probe specific activities of 1-2 X 109 cpm/,ug 
DNA were routinely achieved using the random priming procedure 
[34]. 
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Staining of Keratinocyte Cultures Cell suspensions obtained 
by brief trypsinization were stained with anti-HLA-DR, anti-
ICAM-1, or isotype control IgG monoclonal antibody for 45 min at 
4 ' C. Cell s were washed and then incubated with florescein-conju-
gated anti-mouse IgG for 30 min at 4"C. A Nikon fluorescence 
microscope with epi-illumination was used for scoring. Results are 
expressed as percent of positive cells relative to total viable epider-
mal cell count. 
RESULTS 
Compartmentalization of UM4D4+ T-Cells in Lesional 
Psoriatic Skin To determine whether UM4D4 was expressed by 
lesional T-cells of psoriasis (as occurs in rheumatoid arthritis syno-
vium) [24], the percentage of UM4D4+CD2+ T cells were deter-
mined in histologic sections ofiesional skin biopsies from 7 patients 
wi th acutely expanding psoriatic lesions. Double immunofluores-
cence microscopy demonstrated that 76 ± 13% of the dermal CD2+ 
T cells coexpressed UM4D4 (Fig 1). Both CD4+ and CD8+ T cells 
were UM4D4 positive. In addition to dermal T 'cells, epidermal 
CD2+ cells also expressed UM4D4, although the percentage was 
not determined. 
Peripheral Blood Mononuclear Cells Demonstrate Normal 
Levels of UM4D4+ T Cells Because lesional psoriatic T cells 
contained a high percentage of UM4D4+ T cells, we determined 
whether a similar high level was found in the peripheral blood of 
psoriatic individuals with acutely expand ing lesions. In 8 patients it 
was found that the mean number of UM4D4+CD3+ T cells in 
B 
Figure 1. Double immunofluorescence microscopy of vertical section of lesional psoriatic skin stained with anti -CD2 and anti-UM4D4. A: demonstrates 
CD2+ T cel ls; B: shows the same field and demonstrates UM4D4+ ce ll s. Straight arrows, CD2+UM4D4+ T cells. Cllrved arrow, CD2+UM4D4- T cel ls. Opel/cd 
curved arrow, CD2-UM4D4+ T cells. Magnification X 37.5. 
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peripheral blood was 17 ± 3%, N = 8. This was comparable to the 
number found in the blood of normal volunteers, 21 ± 3%, N = 7. 
Thus, UM4D4+ T ce lls are enriched in lesional skin of patients with 
psoriasis. 
Lesional Psoriatic T-Cell Clones: Phenotype and Expression 
ofUM4D4 To better understand the function of lesional T cells 
and the role of UM4D4 as an activating molecule, a lesional T-cell 
line was derived from involved psoriatic skin. After 2 weeks of 
culture the line was comprised of 69% CD4+CD8- helper/inducer 
T cells and 31 % CD4-CD8+ suppressor/cytotoxic T cells. The line 
was cloned by limiting dilution in the presence of PH A and autolo-
gous feeder cells yielding 21 T -cell clones: 62% CD4+CD.8- and 
38% CD4- C D8+ (Table I). The donal phenotype dlstnbutlon 
(Table I) corresponded roughly to the relative proportion ofT-cell 
subsets in vertical sections of the patient'S lesional psoriatic skin, 
70% CD4+ and 30% CD8+ T cells. The CD4+CD8- T-cell clones 
were heterogenous and were composed of 45% 2H4+ (CD45R+) 
T -cell clones (induce maturation of CD8+ T -suppressor cells (351 
and 55% 2H4- (CD45R- ) T-ce ll clones (provide help for B-cel l 
immunoglobulin production and induce cytotoxic T-celJ develop-
ment) (36J (Table f) . All CD4-CD8+ T-cell clones tested were 
Leu 15- (CD 11b- ) cytotoxic T-cell phenotype [37]. Twelve of 
twelve clones tested were found to be UM4D4+; however, the level 
of UM4D4 expression varied, ranging from 18-95%, with a mean 
of 75% ± 9. UM4D4 was expressed by CD4+2H4+, CD4+2H4-, 
and CD8+CD 11 b- T-cell clones (Table I) . 
Lesional Psoriatic T-Cell Clones: T -Cell Receptor Gene Re-
arrangement Analysis In order to analyze the genotype of these 
T -cell clones, we subjected 4 clones to T-cell receptor gene rear-
rangement analysis. Southern blots were performed on Eco RI- and 
Hind III-digested DNA extracted from each of the clones and hy-
bridized to theJUR-2 cDNA probe (331. which detects the CP1 and 
Cp2·regions of the T-cell receptor beta chain gene (Fig 2A). DNA 
from the squamous cell carcinoma cell line, SCL-l, was used as a 
germline control. A complex set of rearrangements was observed. 
C lones PS 6, PS 14, PS 23 displayed a single non-germline band on 
Eco Rl digestion , indicative of one rearrangement of CP1 in these 
clones. The mobility of the rearranged Eco RI band in clone PS 23 
was very close to that of the germline control, su~~esting that I?J 
recombination event rather than complete VD] Jommg occurred III 
this clone. The intensity of the 3.S-kb Hind 11I band obtained for 
clone PS 10 was double that of clones PS 6, PS 14, and PS 23, 
consistent with the Eco RI data indicating two CP1 rearrangements 
Table 1. Phenotype of T-Cell Clones from Psoriatic Skin 
Clone Phenotype % UM4D4+ %2H4+ % CD11b+ 
PS3 CD4- CDS+ 95 
PS4 CD4+CDS- 95 0 
PS6 CD4+CDS- 95 0 
PSS CD4+CDS-
PS9 CD4+CDS- 1S 35 
PS10 CD4+CDS- 30 95 
PSl1 CD4+CDS- 20 20 
PS14 CD4+CDS- 95 0 
PS15 CD4- CDS+ 
PS16 CD4- CDS+ 95 0 o 
PSI S CD4+CDS- 71 30 
PS2Z CD4- CDS+ 
PS23 CD4- CDS+ 95 0 o 
PS24 CD4+CDS-
PS26 CD4-I-CDS- 95 0 
PS27 CD4+CDS- 95 20 
PS28 CD4- CD8+ ) 
PS31 CD4- CDS+ 
PS32 CD4- CDS+ 
PS33 CD4+CD8-
PS36 CD4+CD8-
.II _ ; not tested. 
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Figure 2. A: Autoradiography of Southern blots. Molecular weights in kd 
are indicated to the left. j , Jurkat T lymphoblastoid cells, positive control; 
SCL-1, squamous cell carcinoma cell line, germline control. The bands 
migrating faster than the 4.2-kb germline bands in clones 14 and 23 are an 
artifact and were not seen in a duplicate experiment. B: Schematic depiction 
of proposed rearrangements. Bands detected by the JUR-Z probe are shown 
at the top or rho figure . Hatched bars, translocation of flanking V-region 
segments. ( ~ ), locations of proposed D-] recombination events. Blark 
bars, locations of Cpt and CpZ gene regions. Exon-intron structures and fin~ 
structures D and J regions are omitted for clarity. 
in this· clone. All four clones displayed at least one rearrangement of 
the 8-kb Hind lIi band, whereas clone PS 14 displayed two rear-
ranged bands. Two of these rearrangements, in clones PS 6 and P 
14, are nearly obscured by cO-llligration with the invariant 6.5-kb 
Hind III band (Fig 2A). Two of the H ind III rearrangements, in 
clones PS 10 and PS 14, yield bands of only sligh tl y greater mobility 
than the germline, suggesting D] rearrangements of CfJ2 similar ro 
that postulated for CP1 in clone PS 23. The patterns of band sizes 
and intensities are consistent with, but do not prove, the patterns at' 
rearran gements depicted in Fig 2B. Taken together with the CD. 
immunophenotyping data, these results suggest that each clone il 
capab le of producing a TCR beta chain product for assembly into ~ 
functional TCR/CD3 complex. Moreover, these data indicate tha\ 
the heterogeneous expression of UM4D4 and 2H4 within clon 
lines was llOt due to polyclonality, but that expression of thes~ 
molecules may vary with the cell cycle or in a stochastic fashion, 
That each clone demonstrated distinct rearrangements indicates th~ 
po lyclonal nature of T cells in psoriatic lesions. 
Both CD4+CDS- and CD4-CDS+ Psoriatic T-Cell CIon 
Respond to Anti-UM4D 4 The high expression of the activat-
ing molecule UM4D4 on psoriatic T cells suggested that UM4D4 
may be a functiona lly important mo lecule in the immunologic com· 
ponent of psoriasis. We therefore tested whether lesional UM4D4" 
T cells actually could respond to anti-UM4D4. Forty-thousand 
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Figure 3. Forty thousand cloned lesional psoriatic CD4+CD8- T cells 
were incubated with media, PMA, anti-UM4D4, or both anti-UM4D4 and 
PMA for 72 h. The resultant T-cell proliferation was measured as J[H]_ TdR 
incorporation. Data are expressed as mean CPM ± SEM of triplicate deter-
minations from a representative experiment. 
T cells from PS 6, a CD4+CD8- T-cell clone, were incubated with 
media, anti-UM4D4, PMA, or the combination of PMA and anti-
UM4D4, for 24 h. Media alone demonstrated only background 
levels of proliferation, whereas anti-UM4D4 induced proliferation 
even in the absence of accessory cells (Fig 3). PMA alone was not 
stimulatory, but together with anti-UM4D4 it was variably comi-
wgenic (Fig 3). Similar results were obtained with six of six other 
CD4+ clones and two of two CD8+CD4- T -cell clones tested. 
Lesional Psoriatic T-Cell Clones Demonstrate Differential 
Release of Gamma-Interferon and Interleukin-2 Because 
anti-UM4d4 activates psoriatic T-cell clones in the absence of added 
stimulator cells or PMA, the antibody provides an ideal reagent for 
the study of Iymphokines released from lesional psoriatic T-cell 
clones in the absence of contaminating cytokines from antigen 
presenting cells. T-cell clones were therefore incubated with and 
without anti-UM4D4 for 24 h. The conditioned media from stimu-
lated and unstimulated T-cell clones were harvested and y-IFN 
activity and IL-2 activity were determined (Fig 4) . To various de-
grees , all 4 clones tested released y-IFN upon stimulation with anti-
UM4D4 (Fig 4, left) . However, only one clone, PS 14, released a 
high amount of y-IFN (62 .5 units/ml). In contrast, this clone re-
leased undetectable levels ofIL-2 (Fig 4, right). Conversely, PS 23, a 
C04+2H4· 
(P$-14) 
Coe+CDll b· 
(PS-23) 
'" 40 00 
~""''''iu/'''' 
2 , 
11.·2 u/onI 
Figure 4. Forty thousand T cells from 4 different clones, PS 6, PS 10, 
PS 14, and PS 23, were stimulated with media or anti-UM4D4. The condi-
tioned media from stimulated and unstimulated T-cell clones were harvested 
after 23 h of culture and both the IL-2 activity and the y-interferon concen-
tration were determined. Shaded bars, conditioned media from activated T 
cells; lit/shaded bars, conditioned media from unactivated T cells. Results are 
expressed in !-tIm!. 
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CD8+Leu15- T-cell clone th at released a high amount of IL-2, 
released low amounts of y-IFN (Fig 4, left). The lack of detectable 
IL-2 activity in the supernatant of PS 14 does not exclude clonal 
production and utilization of IL-2 as an autocrine growth factor; 
that is, hi gh expression of IL-2 receptors by PS14 may absorb se-
creted IL-2, resulting in an apparently low level of extracellular 
IL-2. Activation of each clone was verified by the observation that 
each clone secreted IL-2 receptors into their supernatant following 
ac tivation (data not shown) . Furthermore, 3[H]TdR uptake was 
monitored at the time point when the supernatants were harvested. 
The CD8+ T-cell clone that released a high amount ofIL-2 (PS 23) 
demonstrated the greatest 3[H]TdR uptake (Fig 5). In contrast, the 
C D4+ T-cell clones PS 6, PS 10, and PS 14 that released low 
amounts ofIL-2, showed lower levels of proliferation, regardless of 
whether y-IFN release was high (PS 14) or low (PS 6 and PS 10) (Fig 
5) . Thus, T cells derived frolll lesional psoriatic skin are heteroge-
neous, not only in phenotype, but also in differential release of 
lymphokines in response to a defined stimulus. 
UM4D4-Activated Lesional Psoriatic T-Cell Clones Release 
Lymphokines That Induc~ HLA~DR and ICAM-l Expression 
on Keratinocytes Psonatlc keratlI1ocytes, but not normal kerati-
nocytes, express HLA-DR and ICAM-l in vivo [4,12,13,38] . Ex-
pression of these molecules in vi vo has been attributed to in situ 
release of the lymphokine, y-IFN, by lesional Tcells, because y-IFN 
is reported to induce both HLA-DR and ICAM-1 on cultured epi-
thelial ce lls [16,20]. The demonstration above that there are T-cell 
clones contained in psoriatic lesions capable of producing relatively 
high amounts of y-IFN is supportive of this hypothesis. We next 
asked whether lymphokines (such as the immunoreactive IFN) re-
leased by lesional psoriatic T-cell clones could function to alter 
keratinocytes . We determined the capacity of the conditioned 
media from unactivated and activated T-cell clones to induce kera-
tinocyte cell-surface molecule expression . The conditioned media 
used were the same as those that were assayed for lymphokine con-
tent. The conditioned media from activated and unactivated T-cell 
clones were added to semiconfluent keratinocytes cultured in sup-
plemented MCDB 153 basa l medium at a final dilution of 1:10. 
After 72 h of incubation, the keratinocytes were harvested, stained 
for HLA-DR and ICAM-l, and the percentage of positive cells 
determined using fluorescence microscopy. Keratinocytes incu-
bated with conditioned media from unactivated T-cell clones did 
not express HLA-DR or ICAM-I. In contrast, keratinocytes incu-
bated with conditioned media from stimulated T-cell clones, PS 6, 
PS 10, PS 14, and PS 23, expressed ICAM-1. However, only one 
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Figure 5. Forty thousand T cells from four different clones, PS 6, PS 10, 
PS 14, and PS 23, were incubated with media (ullshaded bars) or anti-
UM4D4 (shaded bars). The resultant T-cell proliferation was measured as 
J[H]_ TdR incorporation. Data are expressed as mean CPM ± SEM of tripli-
cate wells. 
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Table II. UM4D4-activated Psoriatic T-Cell C lones Induce 
Keratinocyte HLA-DR or ICAM-1 Expression" 
Unactivated Activated 
T -Cell Clones % DR % ICAM-l % DR % ICAM-l 
CD4+2H4- 0 0 0 > 95 
(PS6) 
CD4+2H4+ 0 0 0 > 95 
(PS 10) 
CD4+2H4- 0 0 > 95 >95 
(PS1 4) 
CD8+CDllb- 0 0 0 >95 
(PS23) 
• Forty thousand T cells from four differe nc T -cell clo nes were scimulaced with med ia 
or anti-UM4D4. T he conditioned media fro m either activaced or unaccivatcd T -cell 
clones were harvesced afcer 24 h and added to semiconfl uC llC keratinocyre cultures. The 
keracinocyces we re harvested 72 h after addition of condicioned media and che percent-
age that expressed ICAM- l and HLA· DR relative to the to tal number of viable kerati-
nocytes was determined. 
clone, PS 14, the CD4+2H4- clone that released a high amount of 
y-IFN , induced detectable levels of HLA-DR expression on the 
keratinocytes (Table II). 
DISCUSSIO N 
In common with rheumatoid arthritis synovial T cells, lesional 
psoriatic T cell s also demonstrated an increased level of UM4D4 
expression [24] . Immunophenotype of psoriatic skin biopsies 
showed that the majority (76 ± 13%) of dermal CD4+ and CD8+ T 
cel ls expressed UM4D4. UM4D4+ T cells were selectively com-
partmentalized in the skin, because only 17 ± 3% and 21 ± 3% of 
psoriatic and normal blood T cells, respectively, expressed UM4D4. 
C loned T cells from psoriatic lesions also expressed UM4D4 and 
coul d be activated through this pathway to release Iymphokines that 
induce a phenotype displayed on keratinocytes in psoriatic lesions, 
suggesting that this pathway may be relevant in vivo. The enrich-
ment of T cell s expressing UM4D4 was not specific for psoriasis 
because high numbers of UM4D4+ T cells were also found in the 
skin of patients with cutaneous T-cell lymphoma [39]. Thus, in 
addition to inflammatory T cells, UM4D4 may also be an activation 
pathway for malignant T cells in the skin. 
Although T cells from each of the 12 of 12 clones from psoriatic 
skin expressed UM4D4, the level of UM4D4 expression in each 
clone varied. This variation was not due to oligoclonaJity because 
T -ce ll receptor C-beta-chain gene rearrangement analysis was con-
sistent with monoclonality for each clone. Moreover, the rearrange-
ment data suggested that each clone contained at least one function-
ally rearranged receptor, although rigorous proof of this point 
woul d require DNA sequence analysis. Polyclonality also does not 
explain the partial «100%) expression of UM4D4 within the 
cloned lines because recloning ofUM4D4+ T-cell clones results in 
clones with continued levels of UM4D4 expressionless than 100% 
[24] . The percentage of cell s expressing UM4D4 was fairly constant 
over time within a given clone and did not change with activation. 
T he mechanisms responsible for the compartmentalization of 
UM4D4+ T cells in the skin of patients with psoriasis and the 
mechanisms through which such T cells achieve and maintain their 
acti va ted state are unknown. W e have recently shown that two 
conditions for activating T cell s by antigen-dependent mechanisms 
exist in lesional psoriatic skin: 1) elevated epidermal antigen-
presenting cell numbers, and 2) elevated epidermal anti gen-present-
ing function [4]. However, antigen-independent forms of T-cell 
activa tion in this disease may also contribute to T-cell activation . 
T he selective enrichment of UM4D4+ T cells in psoriatic skin, 
synovium, and thymic tissue may be explained by the presence of 
the natu ral ligand for UM4D4 in these compartments. Stimulated 
keratinocytes elaborate a variety of T -cell growth-promoting cyto-
kines including IL-l [40,41J, IL-6 [42], and granulocyte 111acro-
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phage colony-stimulating factor (GM-CSF) [43]. These cytokines 
may be involved in the stimulation of T cells via alternative path-
ways. 
Psoriatic epidermis displays evidence of exposure to T -celilym-
phokines such as y-INF in that keratinocytes from lesional psoriatic 
skin express a number of y-INF inducible surface molecules, in-
cluding HLA-DR [4 ,12,13] , IC AM-1 [11] , and IP-10 [15]. In con-
trast, normal keratinocytes do not express these molecules. Treat-
ment with cyclosporine A, w hich potently inhibits lymphokine 
production by T cells, res ults in rapid loss ofkeratinocyte HLA-DR 
and ICAM-l [44,45]. Speculation is therefore centered on the con-
cept that lesional T cells secrete lymphokines such as y-INF, which 
then induce the expression of these cel l-surface molecules on local 
psoriatic keratinocytes. The direct demonstration of such an inter. 
ac tion between psoriatic T cell s and keratinocytes would be an im-
portant link in this theory . 
W e utilized anti-UM4D4 as a reagent to stimulate the T-cell 
clones to secrete lympb okines into their media without the con-
foundin g effect of accessory cell cytokines also being released into 
the media. In addition, because UM4D4 is highly expressed on 
lesional psoriatic T cell s, and because the ligand could provide a 
non-antigen mediated mechanism ofT-cell activ;ltion in psoriasi 
(and, possibly, normal or other abnormal skin conditions), it may 
indeed be relevant to examine lymphokine production following 
anti-UM4D4 activation. Four T-cell clones with the followin 
phenotypes were chosen for stud y: PS 6, a CD4+UM4D4+2H4-
T-ce ll clone; PS 10, a CD4+UM4D4+2H4+ T-cell clone· 
PS 14, a C D4+UM4 D4+2 H4- T-cell clone, and PS 23, a 
CD8+UM4D4+CD11b- T-ce ll clone. Follow ing stimulation, 
these clones demonstrated differential release of lymphokines. P 
14, which released low amounts of IL-2, released high amounts of 
y-IFN. In contras t, PS 23, which released high amounts of IL-2, 
released low amounts of y-IFN. Thus, the secretion of IL-2 and 
y-IFN may be independently regulated within an individual le-
sional T -cell clone. The results also ra ise the possibility tbat T-cell 
subsets with distinct Iymphokine profil es may interact in psoriatic 
lesions, analogous to helper T-cell subsets in mice that produce 
distinct patterns of cytokines and hypersensitivity reactions [46-
48]. Thus, psoriasis may represent a tilt in the immune balance 
toward a specific type of tissue reaction dictated by a specific balance 
of Iymphokines. 
T he T-cell- conditioned media was assayed for its capacity 
induce keratinocyte expression of ICAM-1 and HLA-DR, surfacr 
molecules expressed on psoriatic keratinocytes but not OIl normal 
keratinocytes. All clones induced ICAM-1 expression on keratino-
cytes; however, only one, PS 23, the clone that released a high 
amount of y-IFN, induced HLA-DR. It is of interest that three ' 
four of the clones preferentiall y induced ICAM-1 and not class II 
molecule expression on the keratinocytes. This is comparable ro 
findings in histologic. sections fro m patients with psorias is, wherr 
keratinocyte ICAM-l expression dominates over class II major hi· 
tocompatibility complex (MHC) molecul e expression [11 ,49]. Be-
cause ICAM-l can be induced by very low levels of y-IFN [49], th~ 
differential induction of ICAM-l and HLA-DR may be due 
different concentrations in the conditioned media. However, it rna' 
also be due to other lymphokines contained in the supernatant that 
preferentially induce ICAM-I. ICAM-1 is an inducible glycopro-
tein that promotes adh esion between the ICAM-l expressing cell 
and lymphocytes in immunologic reactions [20]. The molecule is ~ 
ligand for the lymphocyte-function associated antigen 1 (LFA- l) 
that is variably expressed on nearly all leukocytes (50] . ICAM-1 rna· 
therefore be important for the compartmentalization of T cells in 
psoriasis. Such compartmentalized T cell s may then be activat 
th rough UM4D4 or other mechanisms. 
In conclusion, we have demonstrated a novel alternative T -cell 
activation pathway surface molecule to be highly expressed on psor-
iatic lesional T cells. Activation of psoriatic T cells via this pathway 
resulted in T -cell proliferation and Iymphokine release. Character· 
ization of the T-cell lymphokine profile at the clonal level reveal 
not only differential release of y-IFN and interleukin-2, but al 
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differential capacity to induce keratinocyte ICAM-l and HLA-DR 
expression. Thus, psoriatic lesional T-cell products induce keratino-
cytes to express the phenotype exh ibited by psoriatic keratinocytes. 
These data indicate that lymp hokines released by activated lesional 
psoriatic T cell s in vi tro can be directly involved in keratinocyte 
differentiation and function. 
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The American Contact Dermatitis Society is pleased to announce its second an nual meeting 
and Alexander A. Fisher MD Resident Award. The meeting will be held in Atlanta, Georgia, 
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